Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today ...

Oligonucleotide Synthesis Market Size & Growth Analysis: According to a new report by SNS Insider, the global Oligonucleotide Synthesis Market was valued at USD 3.72 billion in 2023 and is projected ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

April 9, 2025 /PRNewswire/ -- NeuroSense Therapeutics, Ltd. (NASDAQ ... emphasizing PrimeC's targeted biological activity and potential for disease modification. Clinical relevance: miRNA modulation ...

RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Home > Pressemitteilung: The 2025 Else Kröner Fresenius Prize ...

This modification prevents TRIM25 from binding to mRNA ... "Understanding how cells respond to mRNA vaccines is key to improving mRNA therapeutics. To develop effective RNA treatments, we need to find ...

A Shang­hai-based start­up qui­et­ly be­came the first in the world to start a clin­i­cal tri­al for a cir­cu­lar RNA ther­a­py, a cut­ting-edge form of ge­net­ic … ...

Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...